Skip to main content

Study M927

Study name

Zhang Y 2022a

Title

Zhi-zi-chi decoction reverses depressive behaviors in CUMS rats by reducing oxidative stress injury via regulating GSH/GSSG pathway

Overall design

The aim of this study was to explore the antidepressant mechanism and efficacy material basis of Zhi-zi-chi decoction in the chronic unpredictable mild stress (CUMS) model of depression. Sprague-Dawley rats were divided into the following 3 groups (n = 8 in each group): (1) control group, (2) CUMS group, and (3) CUMS + Zhi-zi-chi decoction group (stressor plus Zhi-zi-chi decoction treatment at the dose of 5 g/kg). The CUMS stress procedure lasted for 7 weeks, and drugs were administered via intragastric once per day during the last 2 weeks of the model building period. The brain metabolic profile of depressed rats was analyzed by the method of metabolomics based on ultra-performance liquid chromatography-quadrupole/time-of-flight mass.

Study Type

Type1;

Type2;

Data available

Unavailable

Organism

Rat; Sprague-Dawley rat;

Categories of depression

Animal model; Chronic mild stress model; Chronic mild stress model;

Criteria for depression

Sucrose preference test, forced swimming test, tail suspension test

Sample size

24

Tissue

Central; Brain; Brain;

Platform

MS-based; LC-MS: Agilent 1,260/6,538 UHD Accurate-Mass Q-TOF LC/MS system (Agilent, United States);

PMID

35462900

DOI

10.3389/fphar.2022.887890

Citation

Zhang Y, Fang YC, Cui LX, et al. Zhi-zi-chi decoction reverses depressive behaviors in CUMS rats by reducing oxidative stress injury via regulating GSH/GSSG pathway. Front Pharmacol. 2022 Apr 7;13:887890.

Metabolite

L-Phenylalanine;

L-Tryptophan;

L-Leucine;

L-Methionine;

L-Lysine;

Pantothenic acid;

Creatinine;

D-Ribose;

Inosine;

Dopamine;

S-Adenosylhomocysteine;

Oxidized glutathione;

Glycerophosphocholine;

Aminoadipic acid;

Adenine;

Cytidine;

Cytosine;

Glutathione;

Guanosine;

Sphingosine;

MG(0:0/20:4(5Z,8Z,11Z,14Z)/0:0);

Cysteinylglycine;

Guanine;

6-Hydroxymelatonin;

Fexofenadine;

2-Lysolecithin;